The role of cytokines and arachidonic acid metabolites in the development of airway hyperresponsiveness

Folia Pharmacologica Japonica

Volumn 111, Issue 4, 1998, Pages 233-241

  Nagai, Hiroichi ^a   Tanaka, Hiroyuki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Airway hyperresponsiveness; Arachidonic acid metabolites; Bronchial asthma; Cytokines

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; ANTIASTHMATIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID DERIVATIVE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; LEUKOTRIENE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA; ZAFIRLUKAST; ZILEUTON;

ASTHMA; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; HEREDITY; HUMAN; NONHUMAN; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 0031920845     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.111.233     Document Type: Review

References (50)

1. Cockcroft DW, and Hargreave FE: Airway hyperresponsiveness: Definition, Measurement and Clinical Relevance. In Asthma: Its Pathology and Treatment, Edited by Kaliner MA, Barnes PJ and Persson CGA, pp 51-72, Marcel Dekker, New York (1991)
2. Global Initiative For Asthma. In Definition, pp 2-8, National Institute of Health (1995)
3. Mossmann TR, Cherwinski H, Bond MW, Giedlin MA and Coffman RL: Two types of murine helper T cell clone: Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 2348-2357 (1986)
4. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Kay AB and Hamid Q: Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 92, 397-403 (1993)
5. Ying S, Durham SR, Corrigan CJ, Hamid Q and Kay AB: Phenotype of cells expressing mRNA for Th2-type (interleukin 4 and interleukin 5) and Th 1-type (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am J Respir Cell Mol Biol 12, 477-487 (1995)
6. Lukacs NW, Strieter RM, Chensue SW and Kunkel SL: Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol 10, 526-532 (1994)
7. Coyle AJ, LeGros G, Bertrand C, Tsuyuki S, Heusser CH, Kopf M and Anderson GP: Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 13, 54-59 (1995)
8. Nagai H, Maeda Y and Tanaka H: The effect of anti-IL-4 monoclonal antibody, rapamycin and interferon- γ on airway hyperreactivity to acetyl- choline in mice. Clin Exp Allergy 27, 218-224 (1997)
9. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP and Locksley RM: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183, 109-117 (1996)
10. Brusselle G, Kips J, Joos G, Bluethmann H and Pauwels R: Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 12, 254-259 (1995)
11. Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, DiCosmo B, Tarallo A, Stripp B, Whitsett J and Flavell RA: Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 93, 7821-7825 (1996)
12. Hamid Q, Azzawi M, Ying S, Moqbel R, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, et al: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87, 1541-1546 (1991)
13. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB and Durram SR: Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 156, 704-708 (1997)
14. Iwama T, Hagai H, Tsuruoka N and Koda A: Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs. Clin Exp Allergy 23, 32-38 (1993)
15. Van Oosterhout AJM, Ladenius ARC, Savelkoul HFJ, Van Ark I, Delsman KC and Nijkamp FP: Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 147, 548-552 (1993)
16. Mauser PJ, Pitman A, Witt A, Fernandez X, Zürcher J, Rung T, Jones H, Watnick AS, Egan RW, Kreuther W, et al: Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 148, 1623-1627 (1993)
17. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams III GK, Kreutner W, Egan RW and Chapman RW : Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152, 467-472 (1995)
18. Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Hitoshi Y and Takatsu K: Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci 53, 243-247 (1993)
19. Nagai H, Yamaguchi Y, Maeda Y and Tanaka H: Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin Exp Allergy 26, 642-647 (1996)
20. Yamaguchi Y, Nagai H, Tanaka H, Tsujimoto M and Tsuruoka N: Time course study for antigeninduced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci 54, 471-475 (1994)
21. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI and Young IG: Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183, 195-201 (1996)
22. Lefort J, Bachelet CM, Leduc D and Vargaftig B: Effect of antigen provocation of IL-5 transgenic on eosinophil mobilization and bronchial hyperresponsiveness. J Allergy Clin Immunol 97, 788-799 (1996)
23. Iwamoto T and Takatsu K: Evaluation of airway hyperreactivity in interleukin-5 transgenic mice. Int Arch Allergy Immunol 108, Suppl 1, 28-30 (1995)
24. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneise IE, Horton MA, Haczku A, Gelfand EW, et al: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 185, 2143-2156 (1997)
25. Hogan SP, Koskinen A and Foster PS: Interleukin-5 and eosinophils induces airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 75, 284-288 (1997)
26. Drazen JM, Arm JP and Austen KF: Sorting out the cytokines of asthma. J Exp Med 183, 1-5 (1996)
27. Tanaka H, Nagai H and Maeda Y: Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci (in press)
28. Van der Pouw Kraan TC, Boeije LC, De Groot ER, Stapel SO, Snijders A, Kapsenberg ML, Van der Zee JS and Aarden LA: Reduced production of IL12 and IL-12-dependent IFN- γ release in patients with allergic asthma. J Immunol 158, 5560-5565 (1997)
29. Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ and Hamid Q: Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Grit Care Med 155, 845-851 (1997)
30. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD and Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182, 1527-1536 (1995)
31. Lack G, Renz H, Saloga J, Bradley KL, Loader J, Leung DYM, Larsen G and Gelfand EW: Nebulized but not parenteral IFN- γ decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol 152, 2546-2554 (1994)
32. Li XM, Chopra RK, Chou TY, Schofield BH, Wills-Karp M and Huang SK: Mucosal IFN- γ gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157, 3216-3219 (1996)
33. Selig W and Tocker J: Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol 213, 331-336 (1992)
34. Milne AA, Teixeira MM, Hellewell PG and Piper PJ: Induction of leukocyte recruitment and bronchial hyperresponsiveness in the guinea pig by aerosol administration of interleukin-2. Int Arch Allergy Immunol 108, 60-67 (1995)
35. Xiu Q, Fujimura M, Nomura M, Saito M, Matsuda T, Akao N, Kondo K and Matsushima K: Bronchial hyperresponsiveness and airway neutrophil accumulation induced by interleukin-8 and the effect of the thromboxane A2 antagonist S-1452 in guinea-pigs. Clin Exp Allergy 25, 51-59 (1995)
36. Tang W, Geba GP, Zheng T, Ray P, Homer RJ, Kuhn III C, Flavell RA and Elias JA: Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airway obstruction. J Clin Invest 98, 2845-2853 (1996)
37. Thomas PS, Yates DH and Barnes PJ: Tumor necrosis factor- a increases airway responsiveness and sputumneutrophilia in normal human subjects. Am J Respir Grit Care Med 152, 76-80 (1995)
38. O'Byrne PM, Leikauf GD, Aizawa H, Bethel RA, Ueki IF, Holtzman MJ and Nadel JA: Leukotriene B4 induces airway hyperresponsiveness in dogs. Am J Physiol 59, 1941-1946 (1985)
39. Seeds EA, Kilfeather S, Okiji S, Schoupe TS, Donigi-Gale D and Page CP: Role of lipoxygenase metabolites in platelet-activating factor- and antigen-induced bronchial hyperresponsiveness and eosinophil infiltration. Eur J Pharmacol 293, 369-376 (1995)
40. Arm JP, Spur BW and Lee TH: The effects of inhaled leukotriene E4 on the airway responsiveness in subjects with asthma and normal subjects. J Allergy Clin Immunol 82, 654-660 (1988)
41. Kaye MG and Smith LJ: Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects. Am Rev Respir Dis 141, 993-997 (1990)
42. Nakagawa N, Obata T, Kobayashi T, Okada Y, Nambu F, Terawaki T, Furuya T, Muryobayashi K, Sawada M and Ashita H: Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea pig models of asthma. Eur J Pharmacol 235, 211-219 (1993)
43. Fujimura M, Sakamoto S, Kamio Y and Matsuda T: Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 87, 133-138 (1993)
44. Nagai H, Takeda H, Uno T, Tanaka H and Matsuo A: Effect of a novel leukotriene synthesis inhibitor, BAY x1005, on the antigen- and LPA-induced airway hyperresponsiveness in guinea pigs. Prostaglandins 51, 139-148 (1996)
45. Dahlen B, Kumlin M, Ihre E, Zetterstrom O and Dahlen SE: Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAY x1005. Thorax 52, 342-347 (1997)
46. Jones GL, Saroea HG, Watson RM and O'Byrne PM: Effect of an inhaled thromboxane mimetic (U 46619) on airway function in human subjects. Am Rev Respir Dis 145, 1270-1274 (1992)
47. Saroea HG, Inman MD and O'Byrne PM: U-46619-induced bronchoconstriction in asthmatic subjects is mediated by acetylcholine release. Am J Respir Crit Care Med 151, 321-324 (1995)
48. Hozawa S, Haruta Y, Ishioka S and Yamakido M: Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am J Respir Crit Care Med 152, 1198-1202 (1995)
49. Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, Waga I, Kume K, Miyazaki J and Shimizu T: Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 16, 133-142 (1997)
50. Nagase T, Ishii S, Katayama H, Fukuchi Y, Ouchi Y and Shimizu T: Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor: Roles of thromboxanes and leukotrienes. Am J Respir Crit Care Med 156, 1621-1627 (1997)